Analysts Defend Questcor (QCOR) On Free-Fall In Shares

July 10, 2012 3:19 PM EDT Send to a Friend
Get Alerts QCOR Hot Sheet
Price: $93.60 --0%

Rating Summary:
    7 Buy, 9 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 14 | New: 40
Trade QCOR Now!
Join SI Premium – FREE
Analysts are coming out to defend Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) with today's major sell-off after a negative research piece. However, at this point, it's to no avail.

Piper Jaffray reiterated their Outperform rating and $60 price target saying they do not believe generics are a risk. Even if filed, it would be a minimum 30 month stay. The firm specifically talked to Watson Pharmaceuticals, Inc. (NYSE: WPI), which said they have no plans to pursue filing for a generic version.

Shares of QCOR are down over 20 percent.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Trader Talk

Related Entities

Piper Jaffray

Add Your Comment